GlassScriptPhysician profile
Erin K Petersen
NPI 1952663098
$7,725.36
in general payments reported to CMS, 2019-2025
36 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,185 · 2020: $450 · 2021: $644 · 2022: $818 · 2023: $1,311 · 2024: $1,321 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,511 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,510.59 |
| Education | $118.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,278.11 | 2019-2025 | Aklief, Epsolay, Nemluvio |
| Abbvie INC. | $939.52 | 2019-2025 | Botox, Skyrizi |
| Genzyme Corporation | $545.76 | 2019-2025 | |
| Aclaris Therapeutics, INC. | $500.00 | 2019 | |
| Amgen INC. | $439.20 | 2021-2025 | Otezla, Enbrel, Otezla |
| Arcutis Biotherapeutics, INC. | $330.29 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $300.13 | 2019-2025 | Cabtreo, Arazlo, Jublia |
| Janssen Biotech, INC. | $281.58 | 2019-2024 | Tremfya |
| Ucb, INC. | $275.47 | 2019-2025 | Bimzelx |
| Dermavant Sciences, INC. | $243.41 | 2023-2024 | Vtama |
| Lilly USA, LLC | $233.43 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Mayne Pharma Commercial LLC | $232.02 | 2019-2025 | |
| Revance Therapeutics, INC. | $214.25 | 2024-2025 | Daxxify |
| Incyte Corporation | $196.58 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $171.43 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $166.13 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $161.41 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $134.92 | 2019 | |
| Journey Medical Corporation | $120.65 | 2022 | |
| Epi Health, LLC | $107.86 | 2021-2022 | |
| Almirall LLC | $107.06 | 2021-2023 | Seysara |
| Sanofi-Aventis U.S. LLC | $99.99 | 2020 | |
| Allergan, INC. | $96.47 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $88.91 | 2020-2021 | |
| Merz North America, INC. | $79.08 | 2020 | |
| Celgene Corporation | $64.58 | 2019 | |
| Leo Pharma INC. | $58.74 | 2021-2024 | Adbry |
| Strata Skin Sciences, INC. | $57.30 | 2019 | |
| Encore Dermatology INC. | $38.34 | 2019 | |
| Dermira, INC. | $36.10 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $33.51 | 2022-2023 | Sotyktu |
| Biofrontera INC. | $24.20 | 2019 | |
| Botanix Sb INC | $22.43 | 2025 | Sofdra |
| Dusa Pharmaceuticals, INC. | $21.45 | 2019 | |
| Mission Pharmacal Company | $13.70 | 2020 | |
| Mylan Pharmaceuticals INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.